Wetzel Investment Advisors, Inc. Cidara Therapeutics, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $174 Million
- Q2 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 4,000 shares of CDTX stock, worth $43,600. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$43,600
Previous $3,000
1466.67%
% of portfolio
0.03%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CDTX
# of Institutions
1Shares Held
4KCall Options Held
0Put Options Held
0About Cidara Therapeutics, Inc.
- Ticker CDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,075,696
- Market Cap $764M
- Description
- Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...